Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy

Phase 3 Completed 9 enrolled Aegerion Pharmaceuticals, Inc.

NaSingle-groupOpen-labelTreatment

Summary

Study to Evaluate the Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia (HoFH) on Concurrent Lipid-Lowering Therapy.

Timeline

Start: 2014-04-02
Primary completion: 2015-04-03
Completion: 2015-12-17

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	lomitapide	Small molecule	60 mg	—

Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy

Summary

Timeline

Drugs

Indications